| Health / Medical Topics |
CNDO-109-activated Allogeneic Natural Killer Cells
A preparation of non-interleukin-2 primed, tumor activated allogeneic natural killer (NK) cells with potential immunostimulating activity. The allogeneic NK cells obtained from a first or second degree relative of the patient are co-incubated with a lysate from the CTV-1 cell line, a minimally differentiated myeloid line derived from an acute myelogenous leukemia patient. Infusion of CNDO-109-activated allogeneic NK cells may be able to lyse and destroy NK-resistant tumor cells and a broad spectrum of tumor cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
Human CNBP wild-type allele is located in the vicinity of 3q21 and is approximately 16 kb in length. This allele, which encodes…
This gene is involved in sterol-mediated transcription.
A method for performing probe-level normalization of signal intensity to generate summaries file using CNAT method.
The NCI term type designation for a study code for a drug.
A poloxamer-formulated, bivalent DNA vaccine containing two plasmids encoding both the human cytomegaloviral (CMV) tegument phosphoprotein 65 (pp65), a major internal matrix…
A peptide-based cancer vaccine containing a mutated form of the HLA-A*0201-restricted cytomegaloviral epitope CMVpp65(495-503) with potential immunostimulatory and antitumor activities. Upon subcutaneous…
